Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report)’s share price gapped up before the market opened on Monday after HC ...

In a report released yesterday, Judah Frommer from Morgan Stanley maintained a Buy rating on Bicara Therapeutics Inc. (BCAX – Research Report), ...

BOSTON - Bicara Therapeutics Inc. (NASDAQ:BCAX), a clinical-stage biotech company with a market capitalization of $631 ...

H.C. Wainwright analyst Robert Burns has reiterated their bullish stance on BCAX stock, giving a Buy rating on January 22.Invest with ...

Fintel reports that on January 21, 2025, Cantor Fitzgerald downgraded their outlook for Keros Therapeutics (NasdaqGM:KROS) ...

(“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and ...

Keros Therapeutics (NASDAQ:KROS – Get Free Report) had its target price cut by equities research analysts at Oppenheimer from ...

The most commonly cited valuation measure for stocks is the forward price-to-earnings ratio. This is a stock’s current price divided by the consensus estimate for the company’s earnings per ...

What is the objective of the BetaShares CPS - Global Growth Fund managed fund? The objective of the BetaShares CPS - Global Growth Fund managed fund is The Fund aims to provide capital growth and some ...

LEXINGTON, Mass., Jan. 15, 2025 (GLOBE NEWSWIRE) -- (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics ...

For some organizations, co-leadership starts from the top down. In 2024, when Global Fund for Children (GFC) announced that I would transition from global managing director to co-CEO alongside John ...

Monster Hunter Wilds is hosting open beta test 2 in February, giving us what we assume is the final chance to play ahead of the launch later in the month. Similarly to the open beta test held in ...